Related Experiment Video
Updated: Apr 29, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Quality of life in children with non-cystic-fibrosis bronchiectasis
Yasemin Gokdemir1, Ameer Hamzah, Ela Erdem
1Division of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey.
Insights
Early diagnosis and regular follow-up improve quality of life (QOL) in children with non-cystic-fibrosis bronchiectasis (non-CF BE). Symptom severity correlates with poorer pulmonary function and QOL.
Area of Science:
- Pediatric Pulmonology
- Quality of Life Research
Background:
- Non-cystic-fibrosis bronchiectasis (non-CF BE) remains a significant health issue, particularly in developing nations.
- Assessing the impact of non-CF BE on children's lives is crucial for effective management.
Purpose of the Study:
- To evaluate health-related quality of life (HRQOL) in pediatric non-CF BE patients.
- To identify risk factors associated with HRQOL in this population.
Main Methods:
- Prospective study involving 42 non-CF BE patients aged 9-18 years.
- Utilized Short-Form-36 (SF-36) and St. George's Respiratory Questionnaire (SGRQ) for HRQOL assessment.
- Correlated HRQOL scores with demographic data, pulmonary function, CT findings, and socioeconomic status.
Main Results:
- Significant inverse correlations found between SF-36 and SGRQ subscales, indicating poorer QOL with increased symptoms.
- SGRQ symptom scores correlated positively with frequent antibiotic use and negatively with pulmonary function.
- Longer regular follow-up duration showed an inverse correlation with SGRQ symptom scores.
Conclusions:
- Early diagnosis and consistent follow-up are vital for enhancing QOL in children with non-CF BE.
- Symptom severity and frequency directly impact pulmonary function and overall QOL.
- Development of a disease-specific QOL questionnaire for pediatric non-CF BE is recommended.
Background:
Non-cystic-fibrosis bronchiectasis (non-CF BE) continues to be a problem in developing countries and it is therefore important to examine and assess this disease.
Objectives:
The aims of this prospective study were to evaluate the health-related quality of life (HRQOL) in non-CF BE children and also to assess the risk factors associated with HRQOL.
Methods:
Forty-two non-CF BE patients between the ages of 9 and 18 years were enrolled in the study. All recruited patients completed the generic Short-Form-36 (SF-36), the St. George's Respiratory Questionnaire (SGRQ) for disease-specific QOL scale and forms on socioeconomic status (SES). The extent and severity of CT abnormalities were evaluated by using the modified Bhalla scoring system. Association between HRQOL questionnaires and demographic variables, pulmonary function test, high-resolution CT scores and SES were evaluated.
Results:
SF-36 and SGRQ subscales all correlated inversely with each other (SF-36 physical component summary with SGRQ symptoms score: r = -0.466, p = 0.001, activity score: r = -0.666, p = 0.000 and impact score: r = -0.667, p = 0.000. SF-36 mental component summary with SGRQ symptoms score: r = -0.396, p = 0.005, activity score: r = -0.533, p = 0.000 and impact score: r = -0.512, p = 0.000). There was an inverse correlation between SGRQ symptoms scores and the duration of regular follow-up (r = -0.3, p = 0.04). The symptoms subscale of SGRQ correlated positively with low values for pulmonary function testing (r = -0.417, p = 0.003) and frequent antibiotic requirements (r = 0.303, p = 0.035).
Conclusions:
Early diagnosis and regular follow-up of children with non-CF BE is important for improving their QOL. As expected, the severity and frequency of symptoms are inversely related to the pulmonary function and the QOL scores. A disease-specific questionnaire should be developed to monitor QOL in children with non-CF BE.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History